Diagnostic value of PET/CT for predicting of neoadjuvant chemotherapy response
Seemann, M.D.
European Journal of Medical Research 12(2): 90-91
2007
ISSN/ISBN: 0949-2321 PMID: 17369123 Document Number: 605513
Document emailed within 1 workday
Related Documents
Mamounas, T.P. 2013: Predicting locoregional recurrence after neoadjuvant chemotherapy in patients with breast cancer Clinical Advances in Hematology and Oncology: H&o 11(3): 175-177Su, J.; Chen, H.; Li, M.; Dong, J.; Lin, Z. 2015: Value of FOXP3 Tregs predicting the effectiveness of neoadjuvant chemotherapy in patients with breast cancer Zhonghua Yi Xue Za Zhi 95(8): 595-597
Bacci, G.; Picci, P.; Gherlinzoni, F.; Van Horn, J.R.; Orlandi, M.; Normand, A.R.; Manfrini, M.; Pignatti, G.; Campanacci, M. 1986: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(2): 140-143
Loehberg, C.R.; Lux, M.P.; Ackermann, S.; Poehls, U.G.; Bani, M.R.; Schulz-Wendtland, R.; Papadopoulos, T.; Schmucker, M.; Beckmann, M.W.; Fasching, P.A. 2005: Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used? Anticancer Research 25(3c): 2519-2525
Becker, K.; Mueller, J.; Fink, U.; Busch, R.; Siewert, J.R.; Höfler, H. 2000: Morphologic response evaluation of neoadjuvant chemotherapy of gastric carcinoma Verhandlungen der Deutschen Gesellschaft für Pathologie 84: 164-174
Hui, R.; Zhang, J.; Fan, Y. 2008: Clinical significance of pathological response in the breast cancer after neoadjuvant chemotherapy Zhonghua Yi Xue Za Zhi 88(14): 961-964
Káposztás, Z.; Cseke, L.ás.ó; Kalmár, K.; Horváth, O.P.ét. 2002: Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response Magyar Sebeszet 55(5): 321-324
Splinter, T.A.; Denis, L.; Scher, H.I.; Schröder, F.H.; Dalesio, O. 1989: Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response Progress in Clinical and Biological Research 303: 541-547
Sun, B.; Song, S.-t.; Wu, S.-k.; Jiang, Z.-f.; Wang, T.; Zhang, S.-h.; Zhao, Y.-b.; Yu, C.-z.; Li, X.-b.; Yang, T.; Li, G.-j. 2009: Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients Zhonghua Zhong Liu Za Zhi 31(10): 783-785
Yabusaki, H.; Nashimoto, A.; Tanaka, O. 2002: A complete response after neoadjuvant chemotherapy for advanced gastric cancer with esophageal invasion Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 119-123
Kemmochi, A.; Inagawa, S.; Akashi, Y.; Inagaki, Y.; Satomi, K.; Ohkohchi, N. 2016: A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(1): 115-119
Boonjunwetwat, D.; Prueksadee, J.; Sampatanukul, P.; Chatamra, K. 2005: Does color Doppler ultrasound vascularity predict the response to neoadjuvant chemotherapy in breast cancer? Journal of the Medical Association of Thailand 88(10): 1367-1372
Suematsu, Y.; Yamagishi, S.; Saito, H.; Takahashi, M.; Nakayama, M.; Fukabori, M.; Morita, A.; Wakabayashi, K.; Itoh, Y. 2016: A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2225-2227
Evangelista, L.; Cervino, A.R.; Michieletto, S.; Saibene, T.; Orvieto, E.; Bozza, F.; Ghiotto, C. 2017: Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 61(2): 205-215
Cui, J.; Yang, L.; Guo, L.; Shao, Y.; Li, N.; Zhang, H. 2015: Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer Zhonghua Zhong Liu Za Zhi 37(6): 456-460
Nishino, M.; Hosoda, Y.; Okano, M.; Nagai, K.-i.; Yasui, M.; Kim, Y.; Tsujinaka, T. 2015: A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 2043-2045
Fonseca, E.; Cruz, J.J.; Dueñas, A.; Gómez, A.; Sánchez, P.; Martín, G.; Nieto, A.; Soria, P.; Muñoz, A.; Gómez, J.L.; Pardal, J.L. 1996: Do the conventional clinicopathologic parameters predict for response and survival in head and neck cancer patients undergoing neoadjuvant chemotherapy? Tumori 82(6): 560-566
Timovska, Y.O.; Pivnyuk, V.M.; Oliynichenko, G.P.; Anikushko, M.F.; Zachartseva, L.M.; Chekhun, V.F. 2009: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer Experimental Oncology 31(4): 231-236
Kubota, Y.; Nakano, M.; Nagai, S.; Matsuoka, K.; Arakawa, H.; Horie, K.; Deguchi, T.; Kato, H. 2015: Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report Hinyokika Kiyo. Acta Urologica Japonica 61(1): 33-37
Gonda, K.; Tachiya, Y.; Hatakeyama, Y.; Shibata, M.; Kono, K.; Rokkaku, Y. 2017: Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(10): 944-946